BPC has invested approximately $1.8 million in renovations of this newly constructed facility. The Company expects to add over 40 jobs to Kearney's local economy and currently has employment opportunities available for medical personnel and phlebotomists.
In addition to supporting the local economy through employment opportunities, the Kearney Biotest Plasma Center is actively recruiting local residents to donate plasma. Plasma donors not only contribute the source material for these plasma-derived therapies which save the lives of thousands of patients but are also compensated for their donations.
About Biotest Pharmaceuticals Corporation
Biotest Pharmaceuticals is a wholly-owned subsidiary of Biotest AG, a German global provider of plasma products. The Company researches, develops and manufactures biotherapeutic plasma protein products, with a specialization in immunology and hematology and is a leader in the collection of source plasma. Biotest Pharmaceuticals owns and manages plasmapheresis centers across the United States and operates a state-of-the-art manufacturing facility in Boca Raton, Florida. We are committed to serving the thousands of patients worldwide who rely on plasma-based therapies.
Biotest Pharmaceuticals' team of over 1000 employees is part of Biotest AG's global workforce of more than 2,300 associates worldwide. To learn more about Biotest Pharmaceuticals, our Plasma Centers, and the difference we make in the lives of patients and the healthcare community, please visit us at www.biotestpharma.com and www.biotestplasma.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biotest-pharmaceuticals-corporation-announces-the-opening-of-its-newest-plasma-collection-facility-in-kearney-nebraska-300370555.html
SOURCE Biotest Pharmaceuticals Corporation